false 0001335105 0001335105 2024-12-23 2024-12-23 0001335105 us-gaap:CommonStockMember 2024-12-23 2024-12-23 0001335105 LIXT:WarrantToPurchaseCommonStockMember 2024-12-23 2024-12-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): December 23, 2024

 

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

 

delaware   001-39717   20-2903526

(State or other jurisdiction

of incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

680 East Colorado Boulevard, Suite 180

Pasadena, California 91101

(Address of principal executive offices)

 

(631) 830-7092

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act of 1933 (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(e) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   LIXT   The Nasdaq Stock Market LLC
Warrant to Purchase Common Stock   LIXTW   The Nasdaq Stock Market LLC

 

 

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On December 23, 2024, Eric Forman, the Vice President and Chief Operating Officer of Lixte Biotechnology Holdings, Inc. (the “Company”) provided written notice to the Company of his resignation from such positions, effective as of December 31, 2024. Accordingly, the employment agreement between Mr. Forman and the Company dated July 15, 2020 and subsequently amended on August 12, 2020 and November 6, 2022 will terminate effective as of December 31, 2024.

 

Mr. Forman’s resignation was for personal reasons and was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

 

 
 

 


SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: December 27, 2024 LIXTE BIOTECHNOLOGY HOLDINGS, INC.
  (Registrant)
     
  By: /s/ BASTIAAN VAN DER BAAN
    Bastiaan van der Baan
    Chief Executive Officer

 

 

v3.24.4
Cover
Dec. 23, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 23, 2024
Entity File Number 001-39717
Entity Registrant Name LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Entity Central Index Key 0001335105
Entity Tax Identification Number 20-2903526
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 680 East Colorado Boulevard
Entity Address, Address Line Two Suite 180
Entity Address, City or Town Pasadena
Entity Address, State or Province CA
Entity Address, Postal Zip Code 91101
City Area Code (631)
Local Phone Number 830-7092
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Common Stock [Member]  
Title of 12(b) Security Common Stock
Trading Symbol LIXT
Security Exchange Name NASDAQ
Warrant to Purchase Common Stock  
Title of 12(b) Security Warrant to Purchase Common Stock
Trading Symbol LIXTW
Security Exchange Name NASDAQ
Lixte Biotechnology (NASDAQ:LIXTW)
Historical Stock Chart
From Feb 2025 to Mar 2025 Click Here for more Lixte Biotechnology Charts.
Lixte Biotechnology (NASDAQ:LIXTW)
Historical Stock Chart
From Mar 2024 to Mar 2025 Click Here for more Lixte Biotechnology Charts.